NOMINATIONS - Nouvelle gouvernance chez UbiPharm Gabon et AuditPharma 01 | 01
New Governance at
UbiPharm Gabon and AuditPharma
The UbiPharm Group announces a new stage in the managerial organisation of its subsidiary in Gabon.
Effective 2 January 2026:
- Dr Kenneth AWORE is appointed Managing Director of UbiPharm Gabon.
- Dr Osagyevo NGAKA is appointed Director of Lean Management at AuditPharma, a subsidiary of the UbiPharm Group.
A Doctor of Pharmacy, Kenneth AWORE has built strong expertise in pharmaceutical distribution within the UbiPharm network. After holding operational roles and positions in procurement (UbiPharm Cameroun, then UbiPharm Gabon), he has been leading the commercial division of the Gabon subsidiary since 2021.
.png)
A Doctor of Pharmacy trained in Gabon, Canada and Burkina Faso, Dr Osagyevo NGAKA joined the UbiPharm Group in 2015. He has held roles in operations and business development before serving as Managing Director of UbiPharm Gabon in 2021. As newly appointed Director of Lean Management at AuditPharma, he will oversee the deployment of continuous improvement and operational performance initiatives across the Group’s wholesale subsidiaries, for the benefit of pharmacists and patients.
The UbiPharm Group and UbiPharm Gabon extend their best wishes for success to M. Kenneth AWORE and M. Osagyevo NGAKA in their new positions.
UbiPharm Gabon is the eighth subsidiary of the UbiPharm Group. Created in 1996, it is one of the leading distributors of pharmaceutical products in Gabon. In line with all the Group’s subsidiaries, the company shares the ambition of making healthcare accessible to all.
Gesca is the audit and control subsidiary of the UbiPharm Group and operates on behalf of all Group companies. Its team, based in both France and Côte d’Ivoire (through AuditPharma), works across accounting, legal, pharmaceutical and human resources.
Present in 15 African countries and 4 French overseas departments and regions (DROM), UbiPharm works to facilitate access to healthcare solutions. As a supply chain expert, the Group encompasses five core activities: pharmaceutical wholesaling, distribution, logistics, product promotion and depository services. With an innovative model built on 4,100 pharmacist–client–shareholders and a high-performance, responsible distribution system, UbiPharm is proud to support healthcare stakeholders by fostering close relationships that benefit everyone.